EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications

Erdong Zhang iD, Fengyu Liu, Yongle Wei, Guoqiang Li, Liujie Zheng iD, Lin Jin, Feng Luan, Yingze Zhang, Ling Wang, Zhiyong Hou iD

Immunology · 2026-12 · 179 (4) · 565-578

DOI: 10.1111/imm.70188 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 13.08.2026. Verfasst von Erdong Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Orthopaedic Research Institute of Hebei Province, Shijiazhuang, People's Republic of China. Hauptthemen laut MEDLINE: Adaptor Proteins, Signal Transducing, Autoimmunity, Cytoskeletal Proteins, Autoimmune Diseases. Die Arbeit nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Key Research and Development Program of China, Hebei Provincial Project of Central Government-Guided Local Science and Technology Development Fund, National-Level Scientific Research Innovation Team Cultivation Project of Xinjiang Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune and autoinflammatory diseases are characterised by dysregulated immune activation and persistent inflammation, yet effective mechanism‐based therapeutic targets remain limited. Proline‐serine–threonine phosphatase‐interacting protein 2 (PSTPIP2), a membrane–cytoskeleton‐associated adaptor protein predominantly expressed in myeloid cells, has emerged as an important endogenous regulator of inflammatory responses. This review summarises the molecular structure, expression pattern and biological functions of PSTPIP2, with particular emphasis on its role in coordinating cytoskeletal remodelling, inflammatory signalling and immune‐cell behaviour. We further discuss the major mechanisms through which PSTPIP2 regulates disease progression, including suppression of IL‐1β maturation, inhibition of NF‐κB and ERK signalling, modulation of macrophage polarisation and control of osteoclast‐associated bone remodelling. In addition, recent advances in understanding the involvement of PSTPIP2 in chronic multifocal osteomyelitis, rheumatoid arthritis, SAPHO syndrome and bullous pemphigoid are reviewed, together with evidence from PSTPIP2 ‐deficient models that has provided important mechanistic and translational insights. Finally, the potential value of PSTPIP2 as a biomarker and therapeutic target is highlighted. Overall, PSTPIP2 represents a critical immunoregulatory node linking cytoskeletal organisation to inflammatory control, and further investigation of its molecular functions may facilitate the development of precision therapies for autoimmune and autoinflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adaptor Proteins, Signal TransducingAutoimmunityCytoskeletal ProteinsAutoimmune DiseasesHumansAnimalsSignal TransductionInflammation

Stichwörter der Autor:innen

PSTPIP2autoimmune diseasesautoinflammatory diseasesbiomarkertherapeutic target

Substanzen

Adaptor Proteins, Signal TransducingCytoskeletal Proteins

Autor:innen und Institutionen

  • Orthopaedic Research Institute of Hebei Province, Shijiazhuang, People's Republic of China.
  • Engineering Research Center of Orthopedic Minimally Invasive Intelligent Equipment, Ministry of Education, Shijiazhuang, Hebei, China.
  • Department of Otolaryngology, The Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Orthopedic Oncology, Third Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Key Laboratory of Biomechanics of Hebei Province, Shijiazhuang, China.
  • NHC Key Laboratory of Intelligent Orthopaedic Equipment, Shijiazhuang, China.

ORCID-Profile: Erdong Zhang, Liujie Zheng, Zhiyong Hou

Förderung

  • National Key Research and Development Program of China
  • Hebei Provincial Project of Central Government-Guided Local Science and Technology Development Fund
  • National-Level Scientific Research Innovation Team Cultivation Project of Xinjiang Medical University
  • Hebei Provincial Government Funding Program for Outstanding Clinical Medical Talents

Zitieren

APA

Zhang, E., Liu, F., Wei, Y., Li, G., Zheng, L., Jin, L., Luan, F., Zhang, Y., Wang, L., & Hou, Z. (2026). Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications. Immunology, 179(4), 565-578. https://doi.org/10.1111/imm.70188

Vancouver

Zhang E, Liu F, Wei Y, Li G, Zheng L, Jin L, et al. Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications. Immunology. 2026;179(4):565-578. doi:10.1111/imm.70188

BibTeX
@article{Zhang2026,
  author = {Zhang, Erdong and Liu, Fengyu and Wei, Yongle and Li, Guoqiang and Zheng, Liujie and Jin, Lin and Luan, Feng and Zhang, Yingze and Wang, Ling and Hou, Zhiyong},
  title = {Emerging Roles of PSTPIP2 in Autoimmunity: From Mechanism to Therapeutic Implications},
  journal = {Immunology},
  year = {2026},
  volume = {179},
  number = {4},
  pages = {565--578},
  doi = {10.1111/imm.70188}
}
Kostenlos starten →